Table 3.
Comparisons of phospholipid contents related with elongase and SCD-1 activities in kidney and liver.
| Control (n = 8) | Cyclosporine (n = 8) | Cyclosporine with omega-3 FA (n = 8) | p Value | |
|---|---|---|---|---|
| Kidney | ||||
| Palmitic | 20.7 ± 0.8 | 21.7 ± 0.9* | 22.1 ± 0.4* | .005 |
| Stearic | 23.6 ± 1.6 | 21.5 ± 0.9* | 21.2 ± 0.7* | .015 |
| Elongase (18:0/16:0) | 1.14 ± 0.10 | 0.99 ± 0.03* | 0.96 ± 0.03* | .001 |
| SCD-1 (16:1n7/16:0) | 0.02 ± 0.00 | 0.04 ± 0.00* | 0.04 ± 0.01* | .001 |
| Liver | ||||
| Palmitic | 17.9 ± 1.2 | 17.1 ± 0.5 | 18.5 ± 0.5** | .015 |
| Stearic | 28.9 ± 1.2 | 31.7 ± 0.5* | 28.5 ± 0.4** | .002 |
| Elongase (18:0/16:0) | 1.62 ± 0.14 | 1.86 ± 0.07* | 1.54 ± 0.05** | .006 |
| SCD-1 (16:1n7/16:0) | 0.04 ± 0.01 | 0.04 ± 0.00 | 0.03 ± 0.00*,** | .012 |
Data are expressed as means ± SD.
*p < .05, compared to control group.
**p < .05, compared to cyclosporine group.